Works matching IS 19466234 AND DT 2019 AND VI 11 AND IP 477
Results: 9
Erratum for the Research Article: "The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation" by D. P. Kodack, V. Askoxylakis, G. B. Ferraro, Q. Sheng, M. Badeaux, S. Goel, X. Qi, R. Shankaraiah, Z. A. Cao, R. R. Ramjiawan, D. Bezwada, B. Patel, Y. Song, C. Costa, K. Naxerova, C. S. F. Wong, J. Kloepper, R. Das, A. Tam, J. Tanboon, D. G. Duda, C. R. Miller, M. B. Siegel, C. K. Anders, M. Sanders, M. V. Estrada, R. Schlegel, C. L. Arteaga, E. Brachtel, A. Huang, D. Fukumura, J. A. Engelman, R. K. Jain
- Published in:
- 2019
- Publication type:
- Correction Notice
The more (mutations), the better.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 477, p. N.PAG, doi. 10.1126/scitranslmed.aaw5320
- By:
- Publication type:
- Article
Targeting pacemaker channels in depression.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 477, p. N.PAG, doi. 10.1126/scitranslmed.aaw5318
- By:
- Publication type:
- Article
Squeezing inspiration from embryonic hearts.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 477, p. N.PAG, doi. 10.1126/scitranslmed.aaw5317
- By:
- Publication type:
- Article
Transforming medicine with the microbiome.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 477, p. N.PAG, doi. 10.1126/scitranslmed.aaw1815
- By:
- Publication type:
- Article
Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 477, p. N.PAG, doi. 10.1126/scitranslmed.aau1099
- By:
- Publication type:
- Article
Durable anticancer immunity from intratumoral administration of IL-23, IL-36γ, and OX40L mRNAs.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 477, p. N.PAG, doi. 10.1126/scitranslmed.aat9143
- By:
- Publication type:
- Article
A biologic scaffold–associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 477, p. N.PAG, doi. 10.1126/scitranslmed.aat7973
- By:
- Publication type:
- Article
Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 477, p. N.PAG, doi. 10.1126/scitranslmed.aat3356
- By:
- Publication type:
- Article